Company intelligence / Profile preview

Duck Investors

Ownership: Private
Development stage: Other

Overview

Duck Investors appears to be a private investment firm rather than a life science, biotech, pharma, or healthcare operating company. Public web sources identify it as Duck Investors LLC and classify it within financial services/asset management. Available information indicates it has made at least one disclosed investment, including participation in Phylagen's Series A financing. There is no evidence from the reviewed sources that Duck Investors develops therapeutics, diagnostics, medical devices, or healthcare services.

Industry: Investors

Beyond the preview

Go deeper on Duck Investors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Duck Investors.

Explore the full profile